


NuVessl
Nanotechnology Research • Calgary, Alberta, Canada • 1-10 Employees
Company overview
| Headquarters | 2020, 250 5th St. SW, Calgary, Alberta T2P 0R4, CA |
| Website | |
| NAICS | 541713 |
| SIC | 284 |
| Keywords | Nanotechnology, Consumer Packaged Goods, Pharmaceutical, Product Development, Research And Development, Drug Delivery |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at NuVessl
Brent Bieber
Co-Chief Executive Officer, Co-Founder
NuVessl Email Formats
NuVessl uses 2 email formats. The most common is {first initial} (e.g., j@nuvessl.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@nuvessl.com | 80% |
{first name} | john@nuvessl.com | 20% |
About NuVessl
What We Do: NuVessl develops products to carry active ingredients in innovative and difficult conditions using our patented nanotechnology encapsulation platform. Nano-Lipidic Particle (NLP) Technology: NuVessl's patented NLP technology platform easily, cost-effectively and consistently manufactures 1 nm+ all-natural liposomes that accept single or multiple water-, fat- or bi-soluble AI. Competitive Advantages: ⁄ Deliver individual or different concurrent ingredients ⁄ Custom AI release: rapid, delayed, timed and/or sustained ⁄ Flavour masking or enhancing ⁄ Increased AI lifespan ⁄ Optically clear when AI-loaded ⁄ Dial-a-size custom NLP and assemblies of 1 nm+ ⁄ Inexpensive manufacturing & loading ⁄ Entirely natural, GRAS liposome components (GMO and organic possible) ⁄ Class-leading consistent 85%+ AI loading of liposomes Delivery: Interfaces - Skin, Oral, Nasal, Ocular, Intravenous, Intra-muscular, Pulmonary, Rectal, Ingested, Vaginal, Plant Surfaces Methods - Liquids, Drinks, Sprays, Creams, Pills, Gels, Powders, Emulsions, Lotions, Bandages Intellectual Property Status: Eight core patents protect the know-how related to the manufacture of NLP and encapsulation of AI. NuVessl has specific products or identified solutions in the following segments with over $300 Billion in potential segment sales: ⁄ Pharmaceuticals ⁄ Consumer Goods ⁄ Agriculture and Animal Health NuVessl achieves success through licensing, partnerships and proprietary brands.
NuVessl revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Nanotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
NuVessl has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
NuVessl has never raised funding before.
NuVessl Tech Stack
Discover the technologies and tools that power NuVessl's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Miscellaneous
Hosting
Frequently asked questions
4.8
40,000 users



